Bone-Immune Cell Crosstalk: Bone Diseases

Abstract

Bone diseases are associated with great morbidity; thus, the understanding of the mechanisms leading to their development represents a great challenge to improve bone health. Recent reports suggest that a large number of molecules produced by immune cells affect bone cell activity. However, the mechanisms are incompletely understood. This review aims to shed new lights into the mechanisms of bone diseases involving immune cells. In particular, we focused our attention on the major pathogenic mechanism underlying periodontal disease, psoriatic arthritis, postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, metastatic solid tumors, and multiple myeloma.

A Lox/CHOP‐10 crosstalk governs osteogenic and adipogenic cell fate by MSCs

“…Bone is an active tissue, undergoing continuous remodelling by orchestrated processes of osteoclastic bone resorption and osteoblastic bone formation 33. Various conditions, such as osteoporosis, fracture and rheumatoid arthritis, occur because of loss of normal bone structure, function and homoeostasis 1.…”

Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications

“…GCs mainly affect the trabecular bone inducing an early rapid decline of BMD as a consequence of bone resorption, followed by a slower phase of demineralization due to the impaired OB activity [59].…”

Bone mineral density in girls with Turner's syndrome

“…Зокрема, ФСГ покращує остеокластогенез і резорбцію кісткової тканини безпосередньо шляхом зв'язування з ФСГ-рецептором остеокластів та їх попередників [12,13]. Високі рівні циркулюючого ФСГ були пов'язані з втратою кісткової тканини [14], тоді як зниження рівня ФСГ в сироватці крові внаслідок терапії естрогенами пов'язане з підвищенням кісткової маси [15].…”